Moxifix 400 mg Tablet, manufactured by ACME Laboratories Ltd., is a fourth-generation synthetic fluoroquinolone antibiotic used to treat various bacterial infections. It contains moxifloxacin hydrochloride, which exhibits broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria, including anaerobes and atypical pathogens such as Mycoplasma pneumoniae. Moxifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair